Fernando Lecanda

6.6k total citations
76 papers, 3.7k citations indexed

About

Fernando Lecanda is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fernando Lecanda has authored 76 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 32 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fernando Lecanda's work include Bone health and treatments (17 papers), Bone Metabolism and Diseases (9 papers) and Sarcoma Diagnosis and Treatment (8 papers). Fernando Lecanda is often cited by papers focused on Bone health and treatments (17 papers), Bone Metabolism and Diseases (9 papers) and Sarcoma Diagnosis and Treatment (8 papers). Fernando Lecanda collaborates with scholars based in Spain, United States and France. Fernando Lecanda's co-authors include Roberto Civitelli, Su‐Li Cheng, Thomas H. Steinberg, Louis V. Avioli, Pamela M. Warlow, Carolina Zandueta, Konstantinos Ziambaras, Silvestre Vicent, Sharmin Sheikh and Federico Furlan and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Cell Biology.

In The Last Decade

Fernando Lecanda

76 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernando Lecanda Spain 35 2.4k 1.0k 672 509 474 76 3.7k
Geertje van der Horst Netherlands 31 1.9k 0.8× 1.3k 1.2× 573 0.9× 467 0.9× 212 0.4× 46 3.3k
Evangelia Pardali Netherlands 30 2.2k 0.9× 815 0.8× 617 0.9× 533 1.0× 573 1.2× 47 3.7k
Mitsuyasu Kato Japan 41 3.6k 1.5× 1.0k 1.0× 634 0.9× 464 0.9× 406 0.9× 125 5.4k
Ester Piek Netherlands 27 3.3k 1.4× 998 1.0× 491 0.7× 401 0.8× 326 0.7× 42 4.6k
Brett M. Hall United States 22 2.0k 0.9× 2.1k 2.1× 1.0k 1.6× 380 0.7× 698 1.5× 43 4.7k
Osamu Ohneda Japan 39 2.8k 1.2× 1.1k 1.1× 1.1k 1.7× 284 0.6× 701 1.5× 92 4.9k
David M. Loeb United States 39 2.4k 1.0× 1.2k 1.2× 620 0.9× 1.3k 2.5× 409 0.9× 142 4.6k
R. Grant Rowe United States 26 2.2k 0.9× 908 0.9× 936 1.4× 376 0.7× 346 0.7× 49 3.9k
Nathan Bucay United States 19 3.7k 1.6× 1.6k 1.5× 912 1.4× 502 1.0× 399 0.8× 30 5.0k
K Tognazzi United States 22 2.9k 1.2× 1.2k 1.2× 1.3k 1.9× 578 1.1× 360 0.8× 24 4.4k

Countries citing papers authored by Fernando Lecanda

Since Specialization
Citations

This map shows the geographic impact of Fernando Lecanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Lecanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Lecanda more than expected).

Fields of papers citing papers by Fernando Lecanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Lecanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Lecanda. The network helps show where Fernando Lecanda may publish in the future.

Co-authorship network of co-authors of Fernando Lecanda

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Lecanda. A scholar is included among the top collaborators of Fernando Lecanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Lecanda. Fernando Lecanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valencia, Karmele, Josefina Casas, Luis Botella, et al.. (2023). Cpt1c Downregulation Causes Plasma Membrane Remodelling and Anthracycline Resistance in Breast Cancer. International Journal of Molecular Sciences. 24(2). 946–946. 10 indexed citations
2.
Morales, Xabier, Sergio Ortiz‐Espinosa, Borja Ruiz‐Fernández de Córdoba, et al.. (2022). Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood. Bioengineering & Translational Medicine. 7(3). e10331–e10331. 7 indexed citations
3.
Otero, Irene, Haritz Moreno, Paula Aldaz, et al.. (2022). The Regulators of Peroxisomal Acyl-Carnitine Shuttle CROT and CRAT Promote Metastasis in Melanoma. Journal of Investigative Dermatology. 143(2). 305–316.e5. 17 indexed citations
4.
Rodríguez‐Nogales, Carlos, Haritz Moreno, Carolina Zandueta, et al.. (2020). Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma. Cancers. 12(7). 1895–1895. 9 indexed citations
5.
Ajona, Daniel, Carolina Zandueta, Leticia Corrales, et al.. (2018). Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects. American Journal of Respiratory and Critical Care Medicine. 197(9). 1164–1176. 72 indexed citations
6.
Ajona, Daniel, Sergio Ortiz‐Espinosa, Haritz Moreno, et al.. (2017). A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis. Cancer Discovery. 7(7). 694–703. 187 indexed citations
7.
Ajona, Daniel, et al.. (2017). MA09.01 Dual Blockade of PD-1 and C5a/C5aR Synergistically Protects against Non-Small Cell Lung Cancer Tumor Growth. Journal of Thoracic Oncology. 12(1). S391–S391. 1 indexed citations
8.
Calleja, Lidia Rodriguez, Camille Jacques, François Lamoureux, et al.. (2016). ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis. Cancer Research. 76(11). 3236–3251. 43 indexed citations
9.
Vicent, Silvestre, Naiara Perurena, Ramaswamy Govindan, & Fernando Lecanda. (2015). Bone Metastases in Lung Cancer. Potential Novel Approaches to Therapy. American Journal of Respiratory and Critical Care Medicine. 192(7). 799–809. 26 indexed citations
10.
Yeager, Meredith, L. Phuong, Julie M. Gastier‐Foster, et al.. (2015). Abstract 5574: High prevalence of germline TP53 mutations in young osteosarcoma cases. Cancer Research. 75(15_Supplement). 5574–5574. 4 indexed citations
11.
Weekes, Daniel, Carolina Zandueta, Naiara Perurena, et al.. (2015). Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1. Oncogene. 35(22). 2852–2861. 56 indexed citations
12.
Lamoureux, François, Marc Baud’huin, Lidia Rodriguez Calleja, et al.. (2014). Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle. Nature Communications. 5(1). 3511–3511. 110 indexed citations
13.
Luis-Ravelo, Diego, Iker Antón, Carolina Zandueta, et al.. (2013). RHOB influences lung adenocarcinoma metastasis and resistance in a host‐sensitive manner. Molecular Oncology. 8(2). 196–206. 23 indexed citations
14.
Valencia, Karmele, C. Ormazábal, Carolina Zandueta, et al.. (2012). Inhibition of Collagen Receptor Discoidin Domain Receptor-1 (DDR1) Reduces Cell Survival, Homing, and Colonization in Lung Cancer Bone Metastasis. Clinical Cancer Research. 18(4). 969–980. 116 indexed citations
15.
Antón, Iker, Diego Luis-Ravelo, Carolina Zandueta, et al.. (2012). Receptor of Activated Protein C Promotes Metastasis and Correlates with Clinical Outcome in Lung Adenocarcinoma. American Journal of Respiratory and Critical Care Medicine. 186(1). 96–105. 45 indexed citations
16.
Catena, Raúl, Diego Luis-Ravelo, Iker Antón, et al.. (2010). PDGFR Signaling Blockade in Marrow Stroma Impairs Lung Cancer Bone Metastasis. Cancer Research. 71(1). 164–174. 48 indexed citations
17.
Vicent, Silvestre, Diego Luis-Ravelo, Iker Antón, et al.. (2008). A Novel Lung Cancer Signature Mediates Metastatic Bone Colonization by a Dual Mechanism. Cancer Research. 68(7). 2275–2285. 81 indexed citations
18.
González, Iranzu, Silvestre Vicent, Enrique de Álava, & Fernando Lecanda. (2007). EWS/FLI-1 oncoprotein subtypes impose different requirements for transformation and metastatic activity in a murine model. Journal of Molecular Medicine. 85(9). 1015–1029. 30 indexed citations
19.
Lecanda, Fernando, Pamela M. Warlow, Linda R. Halstead, Thomas H. Steinberg, & Roberto Civitelli. (1998). Impaired intramembranous bone formation in connexin43 null mice. Bone. 23(5). S149–S653. 11 indexed citations
20.
Civitelli, Roberto, Konstantinos Ziambaras, Pamela M. Warlow, et al.. (1998). Regulation of connexin43 expression and function by prostaglandin E 2 (PGE 2 ) and parathyroid hormone (PTH) in osteoblastic cells. Journal of Cellular Biochemistry. 68(1). 8–21. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geertje van der Horst Breakdown of academic impact, for papers by Evangelia Pardali Breakdown of academic impact, for papers by Mitsuyasu Kato Breakdown of academic impact, for papers by Ester Piek Breakdown of academic impact, for papers by Brett M. Hall Breakdown of academic impact, for papers by Osamu Ohneda Breakdown of academic impact, for papers by David M. Loeb Breakdown of academic impact, for papers by R. Grant Rowe Breakdown of academic impact, for papers by Nathan Bucay Breakdown of academic impact, for papers by K Tognazzi
Rankless by CCL
2026